Asia Business News | Saturday, May 17, 2008
email news alerts
RSS 2.0  
Develops innovative therapies which have application to large or unmet markets worldwide, including obesity, pain and diabetes.
Company Fax (03) 9860 5777 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 1998/11/26 
Company Homepage www.metabolic.com.au/
 
Stock Exchange Stock Code
ASXMBP
ADR QUOTEMBLPY
PNKMBLPY
News Reader RSS   METABOLIC PHARMACEUTICALS LIMITED
 Aegis Equities Research Announce Health and Life Science Review, August 2006 (AUG 15, 2006)
Drag Podcast Icon To iTunes - Podcast Download for METABOLIC PHARMACEUTICALS LIMITED
 Metabolic Pharmaceuticals Limited ASX: MBP - 2007 Annual General Meeting - Dr Roland Scollay, CEO (NOV 2, 2007)
 Metabolic Pharmaceuticals Limited ASX: MBP - Metabolic Completes Options Study for Obesity Drug: AOD9604 - Dr Roland Scollay, CEO (DEC 19, 2006)
 Metabolic Pharmaceuticals Limited ASX: MBP - Annual General Meeting - Dr Roland Scollay, CEO (OCT 30, 2006)
 METABOLIC PHARMACEUTICALS LIMITED Forum - Small Caps - Stocks to Watch; ASX: MBP - Dr Roland Scollay, CEO (MAY 8, 2006)